Pateño, Cecile P.

HRN: 28-90-69  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2026
CIPROFLOXACIN 500MG (TAB)
04/27/2026
05/02/2026
PO
500mg
BID
Herniated Nucleus Pulposus L5
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft TissueCentral Nervous System    Compliance to guidelines: